SCHEMBL2233162

SCHEMBL2233162

CCOC(=O)/C=C/c1ccc(Oc2ccc(OCc3ccccc3Cl)cn2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
MAPT P10636 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
NR4A2 P43354 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 3/20 0.41
HPGD P15428 1/20 0.41
THRB P10828 1/20 0.40
CYP3A4 P08684 1/20 0.40
MEN1 O00255 2/20 0.40
ESR1 P03372 1/20 0.40
SLC26A4 O43511 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2236662 0.87 NR4A2 (0.48) MAOAMAOBMAPTSMN1; SMN2NR4A2
SCHEMBL2236651 0.87 NR4A2 (0.48) MAOAMAOBMAPTSMN1; SMN2NR4A2
SCHEMBL13583139 0.80 APP (0.43) MAPTSMN1; SMN2KMT2AHPGDTHRB
SCHEMBL13583137 0.80 APP (0.43) MAPTSMN1; SMN2KMT2AHPGDTHRB
SCHEMBL2233169 0.79 KMT2A (0.47) MAOAMAOBMAPTSMN1; SMN2NR4A2
SCHEMBL13581866 0.79 RECQL (0.48) CA2CA9MAOAMAOBMAPT
SCHEMBL13581865 0.79 RECQL (0.48) CA2CA9MAOAMAOBMAPT
SCHEMBL3147310 0.78 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL3147305 0.78 CA12 (0.52) CA12CA1CA2CA7CA9
SCHEMBL2235535 0.78 SMN1; SMN2 (0.38) MAOAMAOBMAPTSMN1; SMN2NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed